Later age of natural menopause among women with the pathogenic <i>CHEK2</i> c.1100delC variant: a validation study
<i>CHEK2</i> c.1100delC is associated with 1.5-2.2 years later ANM compared with non-carriers, underlining the independence of <i>CHEK2</i> c.1100delC irrespective of heritability of ANM within families.
Authors
- Maartje A. C. Schreurs (ORCID: https://orcid.org/0000-0002-1826-5344)
- M. Ausems
- Marijke R. Wevers
- Yvonne Louwers
- Antoinette Hollestelle
- Muriel A Adank
- Marjanka K Schmidt
- Emma M Vieveen
- Jenny A Visser
- Refika Yigit
- Christi J. van Asperen
- Irma van de Beek
- Charlotte J Dommering
- Maartje J Hooning
- Encarna B. Gomez Garcia
- Margriet J Collee
Institutions
- Radboud University Nijmegen (NL)
- University of Groningen (NL)
- Utrecht University (NL)
- Leiden University Medical Center (NL)
- Erasmus MC (NL)
- Radboud University Medical Center (NL)
- The Netherlands Cancer Institute (NL)
- University Medical Center Utrecht (NL)
- Maastricht University (NL)
- Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NL)
- Erasmus MC Cancer Institute (NL)
- Amsterdam University Medical Centers (NL)
- University of Amsterdam (NL)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- Journal of Medical Genetics
- Published
- 2026-02-13
- DOI
- https://doi.org/10.1136/jmg-2025-111339
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00